Assessment & Adherence

Mood Disorders

Psychopharmacology

Industry-Supported Symposia: Bipolar Depression Across the Life Span: Enhancing Diagnosis and Management from Youth to Older Age

Friday, October 26
7:00 AM - 9:00 AM
Location: Valencia W415 D

Breakfast will be served. Seating for these sessions is available on a first come, first served basis only. Admittance is based on availability and is not guaranteed. Please plan to arrive early to ensure a seat. Breakfast will only be available until 8 AM.

This symposium will feature case-based updates on bipolar depression across the life span. Expert faculty will summarize the latest insights on diagnosis and management of patients with bipolar depression, focusing on children, adolescents, and older adults. The discussion will emphasize practical approaches to differential diagnosis, up-to-date evidence-based treatment strategies, and metabolic and cognitive considerations.

Supported by an educational grant from Sunovion Pharmaceuticals Inc.

Melissa P. DelBello, MD, MS

Dr. Stanley and Mickey Kaplan Professor and Chair of Psychiatry & Behavioral Neuroscience University of Cincinnati College of Medicine Cincinnati, Ohio

Melissa DelBello, MD, MS is Professor of Psychiatry and Pediatrics, Dr. Stanley and Mickey Kaplan Professor and Chair of the Department of Psychiatry and Behavioral Neuroscience and Co-Director of the Division of Bipolar Disorders Research at the University of Cincinnati College of Medicine. Dr. DelBello received her medical degree from the University of Rochester School of Medicine and completed her postgraduate education through psychiatry residencies at the University of Cincinnati College of Medicine and Payne Whitney Psychiatric Clinic of the New York Hospital-Cornell Medical Center. Dr. DelBello completed a clinical fellowship in Child and Adolescent Psychiatry at Cincinnati Children's Hospital Medical Center. She also obtained a master’s degree in Epidemiology and Biostatistics from the University of Cincinnati. Dr. DelBello is a child and adolescent psychiatrist with expertise in the field of the neurodevelopment and treatment of adolescent bipolar disorder. She has been studying pharmacological interventions for, as well as the neurofunction, neurochemistry and outcome of adolescents with and at risk for developing bipolar disorder for over 15 years. She is the principal or co-investigator of many NIH, foundation, and pharmaceutical research grants. In addition to teaching and lecturing both nationally and internationally, she has received numerous awards and honors and has authored or co-authored over 300 peer-reviewed journal articles, reviews, and book chapters.

Presentation(s):

Send Email for Melissa DelBello

Roger S. McIntyre, MD, FRCPC

Professor of Psychiatry and Pharmacology, Head, Mood Disorders Psychopharmacology Unit, University of Toronto, Toronto, Canada; Chairman and Executive Director, Brain and Cognition Discovery Foundation, Toronto, Canada; Director, Depression and Bipolar Support Alliance, Chicago, Illinois; Professor and Nanshan Scholar, Guangzhou Medical University, Guangzhou, China

Roger McIntyre, MD, FRCPC is currently a Professor of Psychiatry and Pharmacology at the University of Toronto and Head of the Mood Disorders Psychopharmacology Unit at the University Health Network, Toronto, Canada. Dr. McIntyre is also Executive Director of the Brain and Cognition Discovery Foundation in Toronto, Canada. In addition, Dr. McIntyre is director for the Depression and Bipolar Support Alliance (DBSA) in Chicago, Illinois, USA, as well as Professor and Nanshan Scholar at the Guangzhou Medical University in Guangzhou, China.

Dr. McIntyre was named by Clarivate Analytics/Thomson Reuters in 2014, 2015, 2016, and 2017 as one of “The World’s Most Influential Scientific Minds.” This distinction is given for publishing the largest number of articles that rank among those most frequently cited by researchers globally in 21 broad fields of science and social science during the previous decade.

Dr. McIntyre is involved in multiple research endeavors that primarily aim to characterize the association between mood disorders, notably cognitive function and medical comorbidity. His work broadly aims to characterize the underlying causes of cognitive impairment in individuals with mood disorders and their impact on workplace functioning. This body of work has provided a platform for identifying novel molecular targets to treat and prevent mood disorders and accompanying cognitive impairment.

Dr. McIntyre is extensively involved in medical education. He is a highly sought-after speaker at both national and international meetings. He has received several teaching awards from the University of Toronto Department of Psychiatry and has been a recipient of the joint Canadian Psychiatric Association (CPA) / Council of Psychiatric Continuing Education Award for the Most Outstanding Continuing Education Activity in Psychiatry in Canada.

Dr. McIntyre is a contributor to the Florida Best Practice Psychotherapeutic Medication Guidelines for Adults with Major Depressive Disorder and Bipolar Disorder. Dr. McIntyre was the co-chair of the Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force on the Treatment of Comorbidity in Adults with Major Depressive Disorder or Bipolar Disorder and a contributor to the CANMAT guidelines for the treatment of Depressive Disorders and Bipolar Disorders. Dr. McIntyre has published more than 400 articles/manuscripts and has edited and/or co-edited several textbooks on mood disorders.

Dr. McIntyre completed his medical degree at Dalhousie University. He received his Psychiatry residency training and Fellowship in Psychiatric Pharmacology at the University of Toronto.

Presentation(s):

Send Email for Roger McIntyre


Assets

Industry-Supported Symposia: Bipolar Depression Across the Life Span: Enhancing Diagnosis and Management from Youth to Older Age



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Industry-Supported Symposia: Bipolar Depression Across the Life Span: Enhancing Diagnosis and Management from Youth to Older Age